International differences in the selection and outcome of minimally invasive and open distal pancreatectomy: A transatlantic analysis.


Journal

Surgery
ISSN: 1532-7361
Titre abrégé: Surgery
Pays: United States
ID NLM: 0417347

Informations de publication

Date de publication:
16 Jul 2024
Historique:
received: 16 12 2023
revised: 02 05 2024
accepted: 13 06 2024
medline: 18 7 2024
pubmed: 18 7 2024
entrez: 17 7 2024
Statut: aheadofprint

Résumé

The efficacy and safety of minimally invasive distal pancreatectomy have been confirmed by randomized trials, but current patient selection and outcome of minimally invasive distal pancreatectomy in large international cohorts is unknown. This study aimed to compare the use and outcome of minimally invasive distal pancreatectomy in North America, the Netherlands, Germany, and Sweden. All patients in the 4 Global Audits on Pancreatic Surgery Group (GAPASURG) registries who underwent minimally invasive distal pancreatectomy or open distal pancreatectomy during 2014-2020 were included. Overall, 20,158 distal pancreatectomies were included, of which 7,316 (36%) were minimally invasive distal pancreatectomies. Use of minimally invasive distal pancreatectomy varied from 29% to 54% among registries, of which 13% to 35% were performed robotically. Both the use of minimally invasive distal pancreatectomy and robotic surgery were the highest in the Netherlands. Patients undergoing minimally invasive distal pancreatectomy tended to have a younger age (Germany and Sweden), female sex (North America, Germany), higher body mass index (North America, the Netherlands, Germany), lower comorbidity classification (North America, Germany, Sweden), lower performance status (Germany), and lower rate of pancreatic adenocarcinoma (all). The minimally invasive distal pancreatectomy group had fewer vascular resections (all) and lower rates of severe complications and mortality (North America, Germany). In the multivariable regression analysis, country was associated with severe complications but not with 30-day mortality. Minimally invasive distal pancreatectomy was associated with a lower risk of 30-day mortality compared with open distal pancreatectomy (odds ratio 1.633, 95% CI 1.159-2.300, P = .005). Considerable disparities were seen in the use of minimally invasive distal pancreatectomy among 4 transatlantic registries of pancreatic surgery. Overall, minimally invasive distal pancreatectomy was associated with decreased mortality as compared with open distal pancreatectomy. Differences in patient selection among countries could imply that countries are in different stages of the learning curve.

Sections du résumé

BACKGROUND BACKGROUND
The efficacy and safety of minimally invasive distal pancreatectomy have been confirmed by randomized trials, but current patient selection and outcome of minimally invasive distal pancreatectomy in large international cohorts is unknown. This study aimed to compare the use and outcome of minimally invasive distal pancreatectomy in North America, the Netherlands, Germany, and Sweden.
METHODS METHODS
All patients in the 4 Global Audits on Pancreatic Surgery Group (GAPASURG) registries who underwent minimally invasive distal pancreatectomy or open distal pancreatectomy during 2014-2020 were included.
RESULTS RESULTS
Overall, 20,158 distal pancreatectomies were included, of which 7,316 (36%) were minimally invasive distal pancreatectomies. Use of minimally invasive distal pancreatectomy varied from 29% to 54% among registries, of which 13% to 35% were performed robotically. Both the use of minimally invasive distal pancreatectomy and robotic surgery were the highest in the Netherlands. Patients undergoing minimally invasive distal pancreatectomy tended to have a younger age (Germany and Sweden), female sex (North America, Germany), higher body mass index (North America, the Netherlands, Germany), lower comorbidity classification (North America, Germany, Sweden), lower performance status (Germany), and lower rate of pancreatic adenocarcinoma (all). The minimally invasive distal pancreatectomy group had fewer vascular resections (all) and lower rates of severe complications and mortality (North America, Germany). In the multivariable regression analysis, country was associated with severe complications but not with 30-day mortality. Minimally invasive distal pancreatectomy was associated with a lower risk of 30-day mortality compared with open distal pancreatectomy (odds ratio 1.633, 95% CI 1.159-2.300, P = .005).
CONCLUSIONS CONCLUSIONS
Considerable disparities were seen in the use of minimally invasive distal pancreatectomy among 4 transatlantic registries of pancreatic surgery. Overall, minimally invasive distal pancreatectomy was associated with decreased mortality as compared with open distal pancreatectomy. Differences in patient selection among countries could imply that countries are in different stages of the learning curve.

Identifiants

pubmed: 39019733
pii: S0039-6060(24)00451-3
doi: 10.1016/j.surg.2024.06.028
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.

Auteurs

Karin U Johansen (KU)

Department of Surgery in Linköping and Department of Biomedical and Clinical Sciences, Linköping University, Sweden.

Simone Augustinus (S)

Department of Surgery, Amsterdam UMC, Location University of Amsterdam, the Netherlands; Cancer Center Amsterdam, the Netherlands.

Ulrich F Wellner (UF)

DGAV StuDoQ|Pancreas Registry and Clinic of Surgery, UKSH Campus Lübeck, Germany.

Bodil Andersson (B)

Department of Clinical Sciences Lund, Surgery, Lund University, Skåne University Hospital, Lund, Sweden.

Joal D Beane (JD)

Department of Surgery, The Ohio State University, Columbus, USA.

Bergthor Björnsson (B)

Department of Surgery in Linköping and Department of Biomedical and Clinical Sciences, Linköping University, Sweden.

Olivier R Busch (OR)

Department of Surgery, Amsterdam UMC, Location University of Amsterdam, the Netherlands; Cancer Center Amsterdam, the Netherlands.

Catherine H Davis (CH)

Department of Surgery, Baylor University Medical Center, Dallas, TX.

Michael Ghadimi (M)

Department of General, Visceral, and Paediatric Surgery, University Medical Centre Göttingen, Germany.

Elizabeth M Gleeson (EM)

Department of Surgery, University of North Carolina at Chapel Hill, USA.

Nine de Graaf (N)

Department of Surgery, Amsterdam UMC, Location University of Amsterdam, the Netherlands; Cancer Center Amsterdam, the Netherlands.

Bas Groot Koerkamp (BG)

Department of Surgery, Erasmus Medical Center, Rotterdam, the Netherlands.

Henry A Pitt (HA)

Rutgers Cancer Institute of New Jersey, New Brunswick, USA.

Hjalmar C van Santvoort (HC)

Department of Surgery, Regional Academic Cancer Center Utrecht, University Medical Center Utrecht and St. Antonius Hospital Nieuwegein, the Netherlands.

Bobby Tingstedt (B)

Department of Clinical Sciences Lund, Surgery, Lund University, Skåne University Hospital, Lund, Sweden.

Waldemar Uhl (W)

Klinik für Allgemein- und Viszeralchirurgie, St. Josef-Hospital Bochum, Klinik der Ruhr-Universität, Bochum.

Jens Werner (J)

Klinik für Allgemein-, Viszeral- und Transplantationschirurgie, Ludwig-Maximilians-Universität, München.

Caroline Williamsson (C)

Department of Clinical Sciences Lund, Surgery, Lund University, Skåne University Hospital, Lund, Sweden.

Marc G Besselink (MG)

Department of Surgery, Amsterdam UMC, Location University of Amsterdam, the Netherlands; Cancer Center Amsterdam, the Netherlands.

Tobias Keck (T)

DGAV StuDoQ|Pancreas Registry and Clinic of Surgery, UKSH Campus Lübeck, Germany. Electronic address: tobias.keck@uksh.de.

Classifications MeSH